
Journal of Cardiology #JCardiol is Official Journal of Japanese College of Cardiology〔日本心臓病学会〕and peer-reviewed cardiovascular journal. 2024 IF is 2.6 !!!
Japan
Joined April 2021
- Tweets5.4K
- Following1.2K
- Followers1.9K
- Likes2.2K
Pinned Tweet
J Cardiol’s 2026 Impact Factor is 3.5
Thanks to all of you!
Our ranking among journals in the cardiovascular category has also been steadily rising: 92/231 in 2024 → 72/237 in 2025.
And best of all, we have “no publication fees” in this day and age, so please do!
#JCardiol
#JCardiol 88(5): 337-43, 2026
Topics: Contemporary TAVR...
[Review]
No-reflow phenomenon during percutaneous coronary intervention: Contemporary insights into mechanisms, prediction, and management
Ozaki Y
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(5): 337-43, 2026
No-reflow phenomenon during percutaneous coronary...
Highlights 3/3
•Prevention focuses on procedural adjustment and adjunctive pharmacotherapy.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(5): 337-43, 2026
No-reflow phenomenon during percutaneous coronary...
Highlights 2/3
•Intracoronary imaging helps identify high-risk plaques and prevention of no-reflow.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(5): 337-43, 2026
No-reflow phenomenon during...
Highlights 1/3
*No-reflow reflects microvascular impairment despite epicardial patency during PCI.
•Mechanisms: distal embolization, reperfusion injury, microvascular dysfunction.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 335-6, 2026
[Letter to the Editors]
Comment on “Beta-blocker therapy for acute myocardial infarction with preserved ejection fraction: A meta-analysis from randomized controlled trials”
Wen S, Ouyang M
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 334, 2026
[Letter to the Editors]
Comment on “Biomarker-based pre-heart failure screening in a middle-aged rural population”
Shabih A
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 333, 2026
[Letter to the Editors]
Early-phase heart rate after ECPR: Prognostic signal, physiologic mediator, or therapeutic target?
Chen J, Ying G
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 331-2, 2026
[Research Letters]
Safety of same-day discharge after mitral transcatheter edge-to-edge repair
Watanabe A et al
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 331-2, 2026
Safety of same-day discharge after...
Highlights 3/3
*Further studies are warranted to identify patients requiring prolonged monitoring.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 331-2, 2026
Safety of same-day discharge after...
Highlights 2/3
*Same-day discharge may be a safe option for eligible patients undergoing M-TEER.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 331-2, 2026
Safety of same-day...
Highlights 1/3
*We examined the safety of same-day discharge following M-TEER from national database.
*The risks of death or readmissions were similar between same- and next-day discharge.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 329-30, 2026
[Research Letters]
Utility of simplified PESI score for mid-term mortality risk stratification: Insights from the combined COMMAND-VTE registries
Kageyama S et al
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 329-30, 2026
Utility of simplified PESI score for mid-term mortality risk stratification...
Highlights 3/3
*Patients with DVT alone had survival similar to PE with an sPESI score of 1.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 329-30, 2026
Utility of simplified PESI score for mid-term mortality risk stratification...
Highlights 2/3
*Higher sPESI scores were associated with stepwise worse mid-term survival.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 329-30, 2026
Utility of simplified PESI...
Highlights 1/3
*Nationwide registry of 8224 Japanese patients with acute venous thromboembolism
*Simplified PESI (sPESI) was associated with 2.6-year all-cause mortality after PE.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 321-8, 2026
Association of 30-second chair stand test performance with exercise intolerance and hospitalization for symptomatic heart failure in type 2 diabetes and stage B heart failure
Sugita Y et al
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 297-320, 2026
Comparative outcomes of balloon-expandable and self-expanding valves in transcatheter aortic valve replacement: A systematic review and meta-analysis
Hafez A et al
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 297-320, 2026
Comparative outcomes of balloon-expandable and...
Highlights 3/3
*Tailored valve selection is key.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 297-320, 2026
Comparative outcomes of balloon-expandable and...
Highlights 2/3
*Self-expanding valves are associated with superior hemodynamics.
*Safety outcomes (bleeding, vascular events, MI) comparable between valve types.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K
#JCardiol 88(4): 297-320, 2026
Comparative outcomes...
Highlights 1/3
*Balloon-expandable valves are associated with reduced early and 12-month mortality.
*Balloon-expandable valves are associated with lower short-term need for new pacemaker.
doi.org/10.1016/j.jjcc.2026.…
by A.E. K




